Home » Topics » Regulatory

Regulatory
RSS

Xeloda approved in E.U. as adjuvant therapy for colon cancer

April 1, 2005

Once-monthly Boniva receives FDA approval

March 31, 2005

Depo-subQ provera 104 approved for management of endometriosis pain

March 31, 2005

Baraclude receives FDA approval

March 31, 2005

Colombian approval for Impavido for cutaneous leishmaniasis

March 29, 2005

Abilify receives new approval

March 9, 2005

Clarinex-D 24 Hour receives FDA approval

March 8, 2005

Controlled release formulations for antiinfective therapy claimed

March 4, 2005

Advitech and the CHULRC to test XP-828L for inflammatory bowel diseases

March 1, 2005

New indications for procarbazine hydrochloride in Japan

March 1, 2005

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...